These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37591867)

  • 1. Circulating tumor cell-derived preclinical models: current status and future perspectives.
    Kahounová Z; Pícková M; Drápela S; Bouchal J; Szczyrbová E; Navrátil J; Souček K
    Cell Death Dis; 2023 Aug; 14(8):530. PubMed ID: 37591867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling.
    Vishnoi M; Liu NH; Yin W; Boral D; Scamardo A; Hong D; Marchetti D
    Mol Oncol; 2019 Sep; 13(9):1913-1926. PubMed ID: 31216110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs).
    Tayoun T; Faugeroux V; Oulhen M; Aberlenc A; Pawlikowska P; Farace F
    Cells; 2019 Sep; 8(10):. PubMed ID: 31557946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
    Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
    Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.
    Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS
    Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells.
    Williams ES; Rodriguez-Bravo V; Chippada-Venkata U; De Ia Iglesia-Vicente J; Gong Y; Galsky M; Oh W; Cordon-Cardo C; Domingo-Domenech J
    J Vis Exp; 2015 Oct; (105):53182. PubMed ID: 26555435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models to study CTCs and CTC culture methods.
    Fernández-Santiago C; López-López R; Piñeiro R
    Int Rev Cell Mol Biol; 2023; 381():57-98. PubMed ID: 37739484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses.
    Suvilesh KN; Nussbaum YI; Radhakrishnan V; Manjunath Y; Avella DM; Staveley-O'Carroll KF; Kimchi ET; Chaudhuri AA; Shyu CR; Li G; Pantel K; Warren WC; Mitchem JB; Kaifi JT
    Mol Cancer; 2022 Mar; 21(1):73. PubMed ID: 35279152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.
    Morrow CJ; Trapani F; Metcalf RL; Bertolini G; Hodgkinson CL; Khandelwal G; Kelly P; Galvin M; Carter L; Simpson KL; Williamson S; Wirth C; Simms N; Frankliln L; Frese KK; Rothwell DG; Nonaka D; Miller CJ; Brady G; Blackhall FH; Dive C
    Ann Oncol; 2016 Jun; 27(6):1155-1160. PubMed ID: 27013395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients.
    Fina E; Cleris L; Dugo M; Lecchi M; Ciniselli CM; Lecis D; Bianchi GV; Verderio P; Daidone MG; Cappelletti V
    J Exp Clin Cancer Res; 2022 Feb; 41(1):78. PubMed ID: 35216615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment.
    Donato C; Szczerba BM; Scheidmann MC; Castro-Giner F; Aceto N
    J Vis Exp; 2019 May; (147):. PubMed ID: 31157780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots.
    Kuo CW; Chueh DY; Chen P
    J Nanobiotechnology; 2019 Feb; 17(1):26. PubMed ID: 30728024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress on the multi-omics and survival status of circulating tumor cells.
    Xie Q; Liu S; Zhang S; Liao L; Xiao Z; Wang S; Zhang P
    Clin Exp Med; 2024 Mar; 24(1):49. PubMed ID: 38427120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
    Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
    Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.
    Schölch S; García SA; Iwata N; Niemietz T; Betzler AM; Nanduri LK; Bork U; Kahlert C; Thepkaysone ML; Swiersy A; Büchler MW; Reissfelder C; Weitz J; Rahbari NN
    Oncotarget; 2016 May; 7(19):27232-42. PubMed ID: 27029058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of circulating tumor cell numbers improves tracking metastatic breast cancer progression.
    Szostakowska-Rodzos M; Fabisiewicz A; Wakula M; Tabor S; Szafron L; Jagiello-Gruszfeld A; Grzybowska EA
    Sci Rep; 2024 Jun; 14(1):12924. PubMed ID: 38839863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.